Recursion Pharmaceuticals, Inc. RXRX Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s price / book?
- Recursion Pharmaceuticals, Inc. (RXRX) reported price / book of 1.6× in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s price / book changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s price / book decreased by 30.5% year-over-year, from 2.3× to 1.6×.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s price / book?
- Over 4 years (2021 to 2025), Recursion Pharmaceuticals, Inc.'s price / book has grown at a -23.1% compound annual growth rate (CAGR), from 5.4× to 1.9×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.